Verastem

Verastem

Verastem

Verastem is a biopharmaceutical company focused on discovering and developing novel drugs that selectively target cancer stem cells.
Raised
$68M
Follow us
Alexa global traffic share
Latest funding Show all
Team Size
10+
Employees
Xconomy

At Verastem, Infinity’s Former Blood Cancer Drug Heads to FDA

Health
Xconomy

Verastem Takes a Low-Cost Flier on Infinity’s Blood Cancer Drug

Health Science
Xconomy

Verastem Sinks as Mesothelioma Study Halted For Futility

Health